Sopharma AD-Sofia (WAR:SPH) Total Inventories : zł828 Mil (As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Sopharma AD-Sofia Total Inventories?

Sopharma AD-Sofia's total inventories for the quarter that ended in Jun. 2024 was zł828 Mil. Sopharma AD-Sofia's average total inventories from the quarter that ended in Mar. 2024 to the quarter that ended in Jun. 2024 was zł809 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Sopharma AD-Sofia's Net-Net Working Capital per share for the quarter that ended in Jun. 2024 was zł-3.35.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sopharma AD-Sofia's Days Inventory for the three months ended in Jun. 2024 was 87.51.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sopharma AD-Sofia's Inventory Turnover for the quarter that ended in Jun. 2024 was 1.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sopharma AD-Sofia's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.76.

Sopharma AD-Sofia Total Inventories Historical Data

The historical data trend for Sopharma AD-Sofia's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Total Inventories Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

501.87

627.83

558.80

608.22

740.85

Sopharma AD-Sofia Quarterly Data
	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Inventories	Get a 7-Day Free Trial															689.75	680.30	740.85	789.56	827.86

Sopharma AD-Sofia Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Sopharma AD-Sofia (WAR:SPH) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Sopharma AD-Sofia's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2024 is

	Net-Net Working Capital Per Share (Q: Jun. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(57.467	+	0.75 * 611.184	+	0.5 * 827.862	-	1445.895
-	0	-	38.753)	/	165.736
=	-3.35

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sopharma AD-Sofia's Days Inventory for the three months ended in Jun. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2024 )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
	=	808.712	/	843.241	*	365 / 4
	=	87.51

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sopharma AD-Sofia's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2024 )	/	Average Total Inventories (Q: Jun. 2024 )
	=	843.241	/	808.712
	=	1.04

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sopharma AD-Sofia's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	808.712	/	1068.43
	=	0.76

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Sopharma AD-Sofia Total Inventories Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (WAR:SPH) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

SFA:Bulgaria

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.